Pragya D. Yadav
#145,936
Most Influential Person Now
Indian researcher
Pragya D. Yadav's AcademicInfluence.com Rankings
Pragya D. Yadavcomputer-science Degrees
Computer Science
#10783
World Rank
#11355
Historical Rank
Machine Learning
#4919
World Rank
#4976
Historical Rank
Artificial Intelligence
#5296
World Rank
#5367
Historical Rank
Database
#7766
World Rank
#8076
Historical Rank
Download Badge
Computer Science
Why Is Pragya D. Yadav Influential?
(Suggest an Edit or Addition)According to Wikipedia, Pragya D. Yadav is an Indian scientist at the ICMR-National Institute of Virology , who is known for her research contributions in the field of communicable diseases and highly pathogenic viral infections, such as Crimean–Congo hemorrhagic fever , Nipah, Ebola, leading to improvising national public health surveillance policy for interventions and management. Yadav is among the scientists who detected the first three COVID-19 pandemic cases in India. She headed the team that developed Covaxin, the first indigenous COVID-19 vaccine in India
Pragya D. Yadav's Published Works
Published Works
- SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India (2021) (284)
- Convergent evolution of SARS-CoV-2 spike mutations, L452R, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India (2021) (246)
- Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees (2021) (229)
- Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial (2021) (229)
- Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial (2021) (188)
- Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020 (2020) (159)
- Outbreak Investigation of Nipah Virus Disease in Kerala, India, 2018. (2018) (158)
- Full-genome sequences of the first two SARS-CoV-2 viruses from India (2020) (145)
- Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial (2021) (115)
- Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B 1.1.7 variant of SARS-CoV-2 (2021) (103)
- Detection, Isolation and Confirmation of Crimean-Congo Hemorrhagic Fever Virus in Human, Ticks and Animals in Ahmadabad, India, 2010–2011 (2012) (100)
- Effect of temperature stress on immature stages and susceptibility of Aedes aegypti mosquitoes to chikungunya virus. (2004) (84)
- Detection of Nipah virus RNA in fruit bat (Pteropus giganteus) from India. (2012) (82)
- Recent Ancestry of Kyasanur Forest Disease Virus (2009) (80)
- Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin (2021) (75)
- Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients (2020) (72)
- Emerging/re-emerging viral diseases & new viruses on the Indian horizon (2019) (72)
- Malsoor Virus, a Novel Bat Phlebovirus, Is Closely Related to Severe Fever with Thrombocytopenia Syndrome Virus and Heartland Virus (2014) (70)
- Evolution, dispersal and replacement of American genotype dengue type 2 viruses in India (1956-2005): selection pressure and molecular clock analyses. (2010) (69)
- Efficacy of Convalescent Plasma Therapy compared to Fresh Frozen Plasma in Severely ill COVID-19 Patients: A Pilot Randomized Controlled Trial (2020) (63)
- Diagnosis of Kyasanur forest disease by nested RT-PCR, real-time RT-PCR and IgM capture ELISA. (2012) (61)
- First isolation of SARS-CoV-2 from clinical samples in India. (2020) (60)
- Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques (2021) (59)
- Th1 skewed immune response of whole virion inactivated SARS CoV 2 vaccine and its safety evaluation (2021) (58)
- Immunogenicity and protective efficacy of BBV152, whole virion inactivated SARS- CoV-2 vaccine candidates in the Syrian hamster model (2021) (58)
- Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG (2020) (55)
- Predominance of delta variant among the COVID-19 vaccinated and unvaccinated individuals, India, May 2021 (2021) (52)
- On the transmission pattern of Kyasanur Forest disease (KFD) in India (2015) (52)
- Efficacy, safety, and lot to lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): a double-blind, randomised, controlled phase 3 trial (2021) (50)
- Thottapalayam virus is genetically distant to the rodent-borne hantaviruses, consistent with its isolation from the Asian house shrew (Suncus murinus) (2007) (49)
- Kyasanur Forest Disease, India, 2011–2012 (2013) (48)
- SARS CoV-2 variant B.1.617.1 is highly pathogenic in hamsters than B.1 variant (2021) (48)
- Nipah Virus Sequences from Humans and Bats during Nipah Outbreak, Kerala, India, 2018 (2019) (47)
- Neutralization of UK-variant VUI-202012/01 with COVAXIN vaccinated human serum (2021) (47)
- A Systemic Review on Staphylococcal Scalded Skin Syndrome (SSSS): A Rare and Critical Disease of Neonates (2016) (47)
- Complete genome sequencing of Kaisodi virus isolated from ticks in India belonging to Phlebovirus genus, family Phenuiviridae. (2019) (45)
- Neutralization against B.1.351 and B.1.617.2 with sera of COVID-19 recovered cases and vaccinees of BBV152 (2021) (44)
- Spread of Kyasanur Forest Disease, Bandipur Tiger Reserve, India, 2012–2013 (2013) (43)
- Nosocomial infection of CCHF among health care workers in Rajasthan, India (2016) (42)
- Clinical Characterization and Genomic Analysis of Samples from COVID-19 Breakthrough Infections during the Second Wave among the Various States of India (2021) (42)
- Expediency of dengue illness classification: the Sri Lankan perspective Highly infectious tick-borne viral diseases: Kyasanur forest disease and Crimean-Congo haemorrhagic fever in India (2014) (41)
- Buffalopox outbreak in humans and animals in Western Maharashtra, India. (2011) (41)
- Genomic analysis of SARS-CoV-2 strains among Indians returning from Italy, Iran & China, & Italian tourists in India (2020) (41)
- Antibodies Elicited in Response to EBNA-1 May Cross-React with dsDNA (2010) (41)
- Zika virus outbreak in Rajasthan, India in 2018 was caused by a virus endemic to Asia. (2019) (40)
- Genetic characterization and molecular clock analyses of the Crimean-Congo hemorrhagic fever virus from human and ticks in India, 2010-2011. (2013) (39)
- Laboratory preparedness for SARS-CoV-2 testing in India: Harnessing a network of Virus Research & Diagnostic Laboratories (2020) (36)
- New focus of Kyasanur Forest disease virus activity in a tribal area in Kerala, India, 2014 (2015) (35)
- Outbreak of Kyasanur Forest disease in Thirthahalli, Karnataka, India, 2014. (2014) (34)
- Isolation and characterization of the new SARS-CoV-2 variant in travellers from the United Kingdom to India: VUI-202012/01 of the B.1.1.7 lineage (2021) (34)
- Recent Scenario of Emergence of Kyasanur Forest Disease in India and Public Health Importance (2016) (34)
- Neutralization potential of Covishield vaccinated individuals sera against B.1.617.1 (2021) (33)
- Zika virus: Indian perspectives (2016) (32)
- Outbreak of Kyasanur Forest disease (monkey fever) in Sindhudurg, Maharashtra State, India, 2016. (2016) (32)
- Experimental transmission of Chikungunya virus by Anopheles stephensi mosquitoes. (2003) (32)
- Clinical & epidemiological significance of Kyasanur forest disease (2018) (32)
- Imported SARS-CoV-2 V501Y.V2 variant (B.1.351) detected in travelers from South Africa and Tanzania to India (2021) (29)
- Biorisk assessment for infrastructure & biosafety requirements for the laboratories providing coronavirus SARS-CoV-2/(COVID-19) diagnosis (2020) (29)
- Effect of temperature and insecticide stresses on Aedes aegypti larvae and their influence on the susceptibility of mosquitoes to dengue-2 virus. (2005) (28)
- First two cases of Monkeypox virus infection in travellers returned from UAE to India, July 2022 (2022) (28)
- Neutralization of Delta variant with sera of Covishield™ vaccinees and COVID-19-recovered vaccinated individuals (2021) (28)
- SARS-CoV-2 Delta Variant Pathogenesis and Host Response in Syrian Hamsters (2021) (26)
- Genomic analysis reveals Nairobi sheep disease virus to be highly diverse and present in both Africa, and in India in the form of the Ganjam virus variant. (2011) (26)
- Cross-sectional Serosurvey of Crimean-Congo Hemorrhagic Fever Virus IgG in Livestock, India, 2013–2014 (2015) (26)
- Comparison of the immunogenicity & protective efficacy of various SARS-CoV-2 vaccine candidates in non-human primates (2020) (25)
- Clinical characterization and Genomic analysis of COVID-19 breakthrough infections during second wave in different states of India (2021) (25)
- Emergence of Crimean-Congo hemorrhagic fever in Amreli District of Gujarat State, India, June to July 2013. (2014) (25)
- Remarkable immunogenicity and protective efficacy of BBV152, an inactivated SARS-CoV-2 vaccine in rhesus macaques (2020) (25)
- Occupational exposure of cashew nut workers to Kyasanur Forest disease in Goa, India. (2017) (25)
- Genotyping of Chikungunya virus isolates from India during 1963-2000 by reverse transcription-polymerase chain reaction. (2003) (24)
- Isolation of a Novel Adenovirus from Rousettus leschenaultii Bats from India (2012) (24)
- Establishment of Biosafety Level-3 (BSL-3) laboratory: Important criteria to consider while designing, constructing, commissioning & operating the facility in Indian setting (2014) (23)
- Vector biology of dengue & chikungunya viruses. (2006) (23)
- Equine Encephalosis Virus in India, 2008 (2018) (23)
- An Epidemiological Analysis of SARS-CoV-2 Genomic Sequences from Different Regions of India (2021) (22)
- Refractory giardiasis: a molecular appraisal from a tertiary care centre in India. (2014) (22)
- First laboratory confirmation on the existence of Zika virus disease in India. (2017) (22)
- Neutralization of B.1.1.28 P2 variant with sera of natural SARS-CoV-2 infection and recipients of inactivated COVID-19 vaccine Covaxin (2021) (21)
- Comparable neutralization of SARS-CoV-2 Delta AY.1 and Delta in individuals sera vaccinated with BBV152 (2021) (21)
- Safety and immunogenicity clinical trial of an inactivated SARS-CoV-2 vaccine, BBV152 (a phase 2, double-blind, randomised controlled trial) and the persistence of immune responses from a phase 1 follow-up report (2020) (21)
- Detection of coronaviruses in Pteropus & Rousettus species of bats from different States of India (2020) (21)
- Laboratory-Confirmed Avian Influenza A(H9N2) Virus Infection, India, 2019 (2019) (21)
- Evaluation of the susceptibility of mice & hamsters to SARS-CoV-2 infection (2020) (21)
- Neutralization of VUI B.1.1.28 P2 variant with sera of COVID-19 recovered cases and recipients of Covaxin an inactivated COVID-19 vaccine (2021) (21)
- Crimean-Congo Hemorrhagic Fever in Migrant Worker Returning from Oman to India, 2016 (2017) (20)
- Comparison of the pathogenicity and virus shedding of SARS CoV-2 VOC 202012/01 and D614G variant in hamster model (2021) (20)
- Crimean Congo hemorrhagic fever serosurvey in humans for identifying high-risk populations and high-risk areas in the endemic state of Gujarat, India (2019) (20)
- Experimental Zika virus infection in Aedes aegypti: Susceptibility, transmission & co-infection with dengue & chikungunya viruses (2018) (20)
- Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern (2022) (19)
- Substantial immune response in Omicron infected breakthrough and unvaccinated individuals against SARS-CoV-2 variants of concern (2022) (19)
- Role of Gregarine Parasite Ascogregarina culicis (Apicomplexa: Lecudinidae) in the Maintenance of Chikungunya Virus in Vector Mosquito (2003) (19)
- Phylogeography of Kyasanur Forest Disease virus in India (1957–2017) reveals evolution and spread in the Western Ghats region (2020) (18)
- Crimean-Congo Hemorrhagic Fever: Current Scenario in India (2013) (18)
- Isolation and characterization of SARS-CoV-2 Beta variant from UAE travelers (2021) (17)
- Comparable neutralization of SARS-CoV-2 Delta AY.1 and Delta with individuals sera vaccinated with BBV152 (2021) (17)
- Isolation and characterization of VUI-202012/01, a SARS-CoV-2 variant in travellers from the United Kingdom to India. (2021) (17)
- Establishment of cell line from embryonic tissue of Pipistrellus ceylonicus bat species from India & its susceptibility to different viruses (2013) (17)
- Neutralization potential of Covishield vaccinated individuals sera against B.1.617.1. (2021) (16)
- Molecular characterization of clinical isolates of Cyclospora cayetanensis from patients with diarrhea in India (2015) (16)
- Isolation and Characterization of Densonucleosis Virus from Aedes aegypti Mosquitoes and Its Distribution in India (2009) (16)
- Serosurvey of Crimean-Congo hemorrhagic fever virus in domestic animals, Gujarat, India, 2013. (2014) (16)
- Infections among Contacts of Patients with Nipah Virus, India (2019) (16)
- Effectiveness of BBV152/Covaxin and AZD1222/Covishield vaccines against severe COVID-19 and B.1.617.2/Delta variant in India, 2021: a multi-centric hospital-based case-control study (2022) (15)
- Prevalence and spatial distribution of Ixodid tick populations in the forest fringes of Western Ghats reported with human cases of Kyasanur forest disease and monkey deaths in South India (2018) (15)
- Re-occurrence of Crimean-Congo haemorrhagic fever in Ahmedabad, Gujarat, India (2012): a fatal case report (2013) (14)
- First confirmed case of Crimean-Congo haemorrhagic fever from Sirohi district in Rajasthan State, India (2015) (14)
- Circulation of Nipah virus in Pteropus giganteus bats in northeast region of India, 2015 (2018) (14)
- Kyasanur Forest Disease Prevalence in Western Ghats Proven and Confirmed by Recent Outbreak in Maharashtra, India, 2016. (2018) (14)
- Evaluation of Safety and Immunogenicity of an Adjuvanted, TH-1 Skewed, Whole Virion InactivatedSARS-CoV-2 Vaccine - BBV152 (2020) (14)
- Immunogenicity and protective efficacy of BBV152: a whole virion inactivated SARS CoV-2 vaccine in the Syrian hamster model (2020) (13)
- Distribution and prevalence of ticks on livestock population in endemic area of Kyasanur forest disease in Western Ghats of Kerala, South India (2019) (13)
- Molecular characterisation of Giardia intestinalis assemblages from human isolates at a tertiary care centre of India. (2014) (13)
- Study of Kyasanur forest disease viremia, antibody kinetics, and virus infection in target organs of Macaca radiata (2020) (13)
- Experiential learnings from the Nipah virus outbreaks in Kerala towards containment of infectious public health emergencies in India (2020) (13)
- Assessment of immunogenicity and protective efficacy of ZyCoV-D DNA vaccine candidates in Rhesus macaques against SARS-CoV-2 infection (2021) (12)
- Detection of Nipah virus in Pteropus medius in 2019 outbreak from Ernakulam district, Kerala, India (2021) (12)
- Molecular characterization of Chittoor (Batai) virus isolates from India (2012) (12)
- Characterization of Novel Reoviruses Wad Medani Virus (Orbivirus) and Kundal Virus (Coltivirus) Collected from Hyalomma anatolicum Ticks in India during Surveillance for Crimean Congo Hemorrhagic Fever (2019) (12)
- Mapping an epitope in EBNA‐1 that is recognized by monoclonal antibodies to EBNA‐1 that cross‐react with dsDNA (2016) (12)
- Neutralization of B.1.1.28 P2 variant with sera of natural SARS-CoV-2 infection and recipients of BBV152 vaccine (2021) (11)
- Isolation of SARS-CoV-2 B.1.1.28.2 P2 variant and pathogenicity comparison with D614G variant in hamster model (2021) (11)
- Booster dose of the inactivated COVID-19 vaccine BBV152 (Covaxin) enhances the neutralizing antibody response against alpha, Beta, Delta and omicron variants of concern. (2022) (11)
- Elevated neutralization of Omicron with sera of COVID-19 recovered and breakthrough cases vaccinated with Covaxin than two dose naïve vaccinees (2022) (11)
- Evaluation of Safety and Immunogenicity of an Adjuvanted, TH-1 Skewed, Whole Virion Inactivated SARS-CoV-2 Vaccine - BBV152 (2020) (11)
- Factors associated with mortality among moderate and severe patients with COVID-19 in India: a secondary analysis of a randomised controlled trial (2021) (11)
- A qualitative IgG ELISA for detection of SARS-CoV-2-specific antibodies in Syrian hamster serum samples (2021) (11)
- Molecular diversity of Coxsackievirus A10 circulating in the southern and northern region of India [2009-17]. (2018) (10)
- Canine Distemper Virus in Asiatic Lions of Gujarat State, India (2019) (10)
- Retrospective analysis of clinical information in Crimean-Congo haemorrhagic fever patients: 2014-2015, India (2017) (10)
- Serendipitous COVID-19 Vaccine-Mix in Uttar Pradesh, India: Safety and Immunogenicity Assessment of a Heterologous Regime (2021) (10)
- A mini-review of Bunyaviruses recorded in India (2017) (10)
- Kinetics of viral RNA, immunoglobulin-M & G antibodies in Kyasanur forest disease (2019) (9)
- Longitudinal clinico-serological analysis of anti-nucleocapsid and anti-receptor binding domain of spike protein antibodies against SARS-CoV-2 (2021) (9)
- Isolation of bovine viral diarrhea virus 1, a pestivirus from autopsied lamb specimen from Tamil Nadu, India. (2004) (9)
- Performance evaluation of Truenat™ Beta CoV & Truenat™ SARS-CoV-2 point-of-care assays for coronavirus disease 2019. (2020) (9)
- Ebola virus outbreak preparedness plan for developing Nations: Lessons learnt from affected countries. (2021) (9)
- Respiratory virus detection among the overseas returnees during the early phase of COVID-19 pandemic in India (2020) (9)
- Safety and immunogenicity trial of an inactivated SARS-CoV-2 vaccine-BBV152: a phase 1, double-blind, randomised control trial (2020) (9)
- Difference in vector ticks dropping rhythm governs the epidemiology of Crimean-Congo haemorrhagic fever & Kyasanur forest disease in India (2016) (8)
- Clonal diversity and drug resistance in Mycobacterium tuberculosis isolated from extra-pulmonary samples in central India--a pilot study. (2014) (8)
- Immunogenicity and safety of a heterologous prime-boost COVID-19 vaccine schedule: ChAdOx1 vaccine Covishield followed by BBV152 Covaxin (2021) (8)
- Isolation of Tioman virus from Pteropus giganteus bat in North-East region of India (2016) (8)
- Identification and characterization of novel mosquito-borne (Kammavanpettai virus) and tick-borne (Wad Medani) reoviruses isolated in India. (2018) (8)
- Inactivation of SARS-CoV-2 by gamma irradiation. (2020) (8)
- Development of single step RT-PCR for detection of Kyasanur forest disease virus from clinical samples (2018) (8)
- Isolation and molecular characterization of coxsackievirus A6 and coxsackievirus A16 from a case of recurrent Hand, Foot and Mouth Disease in Mumbai, Maharashtra, India, 2018 (2020) (8)
- Comparison of SARS-CoV-2 Variants of Concern 202012/01 (U.K. Variant) and D614G Variant Transmission by Different Routes in Syrian Hamsters. (2021) (7)
- Characterization of Unknown Orthobunya-Like Viruses from India (2018) (7)
- Development of double antibody sandwich ELISA as potential diagnostic tool for rapid detection of Crimean-Congo hemorrhagic fever virus (2021) (7)
- Molecular characterization of Umbre virus (Bunyaviridae) (2008) (7)
- Transcriptome & viral growth analysis of SARS-CoV-2-infected Vero CCL-81 cells (2020) (7)
- Preparedness of public health-care system for Zika virus outbreak: An Indian perspective. (2020) (7)
- Clinical presentation, viral kinetics, and management of human monkeypox cases from New Delhi, India 2022 (2022) (7)
- Isolation and characterization of Oya virus a member of Simbu serogroup, family Bunyaviridae, isolated from Karnataka, India. (2016) (7)
- Persistence of IgG antibodies in survivors of Crimean Congo hemorrhagic fever virus infection, India. (2019) (6)
- Global emergence of SARS-CoV-2 variants: new foresight needed for improved vaccine efficacy (2021) (6)
- An Early Passage Human Isolate of Kyasanur Forest Disease Virus Shows Acute Neuropathology in Experimentally Infected CD-1 Mice. (2016) (6)
- Persistence of immunity and impact of third dose of inactivated COVID-19 vaccine against emerging variants (2022) (6)
- Protective Immunity of the Primary SARS-CoV-2 Infection Reduces Disease Severity Post Re-Infection with Delta Variants in Syrian Hamsters (2021) (6)
- Development of equine antisera with high neutralizing activity against SARS-CoV-2 (2020) (6)
- A spatial association between a Nipah virus outbreak in Kozhikode, Kerala, India and Nipah virus infection in Pteropus bats. (2019) (6)
- Characterization of a strain of quaranfil virus isolated from soft ticks in India. Is quaranfil virus an unrecognized cause of disease in human and animals?” (2019) (6)
- Genome characterization of monkeypox cases detected in India: Identification of three sub clusters among A.2 lineage (2022) (6)
- Performance assessment of seven SARS‐CoV‐2 IgG enzyme‐linked immunosorbent assays (2021) (5)
- Detection of possible Nipah virus infection in Rousettus leschenaultii and Pipistrellus Pipistrellus bats in Maharashtra, India. (2021) (5)
- Natural Selection Plays an Important Role in Shaping the Codon Usage of Structural Genes of the Viruses Belonging to the Coronaviridae Family (2020) (5)
- Isolation and Genomic Characterization of SARS-CoV-2 Omicron Variant Obtained from Human Clinical Specimens (2022) (5)
- Detection of African genotype in Hyalomma tick pools during Crimean Congo Hemorrhagic Fever outbreak, Rajasthan, India, 2019. (2020) (5)
- Clinico-epidemiological and genomic profile of first Zika Virus outbreak in India at Jaipur city of Rajasthan state. (2020) (5)
- Clinico epidemiological profile of Omicron variant of SARS CoV2 in Rajasthan (2022) (5)
- First isolation of SARS-CoV-2 from clinical samples in India (2020) (5)
- An in vitro and in vivo approach for the isolation of Omicron variant from human clinical specimens (2022) (5)
- Isolation and phylogenomic analysis of Buffalopox virus from Human and Buffaloes in India. (2019) (5)
- Substantial immune response in Omicron infected breakthrough and unvaccinated individuals against SARS-CoV-2 variants of concerns (2022) (5)
- Quasispecies analysis of the SARS-CoV-2 from representative clinical samples: A preliminary analysis (2020) (5)
- Genome Sequencing Reveals a Mixed Picture of SARS-CoV-2 Variant of Concern Circulation in Eastern Uttar Pradesh, India (2022) (4)
- SARS-CoV-2 & influenza A virus co-infection in an elderly patient with pneumonia (2021) (4)
- Nipah Virus Outbreak in Kerala State, India Amidst of COVID-19 Pandemic (2021) (4)
- Detection of Zika virus disease in Thiruvananthapuram, Kerala, India 2021 during the second wave of COVID‐19 pandemic (2022) (4)
- Studies on mutations in embB locus in Indian clinical isolates of Mycobacterium tuberculosis having high degree of ethambutol resistance (2006) (4)
- Use of hydrogen peroxide vapour & plasma irradiation in combination for quick decontamination of closed chambers (2016) (4)
- Zika a Vector Borne Disease Detected in Newer States of India Amidst the COVID-19 Pandemic (2022) (4)
- Enhanced esterase activity in salivary gland and midgut of Aedes aegypti mosquito infected with dengue-2 virus. (2003) (3)
- Animal models for some important RNA viruses of public health concern in SEARO countries: viral hemorrhagic fever. (2015) (3)
- Clinical profile and outcome of patients with Crimean Congo haemorrhagic fever: a hospital based observational study from Rajasthan, India. (2020) (3)
- Laboratory surveillance of chikungunya in Madhya Pradesh, India (2016-2017) (2020) (3)
- Immune responses against different variants of SARS-CoV-2 including omicron following six months of administration of heterologous prime-boost COVID-19 vaccine (2022) (3)
- Antibody response in symptomatic & asymptomatic Nipah virus cases from Kerala, India (2021) (3)
- Development of polymerase chain reaction-based diagnostic tests for detection of Malsoor virus & adenovirus isolated from Rousettus species of bats in Maharashtra, India (2017) (3)
- ZRC3308 Monoclonal Antibody Cocktail Shows Protective Efficacy in Syrian Hamsters against SARS-CoV-2 Infection (2021) (3)
- Differential Cell Line Susceptibility to the SARS-CoV-2 Omicron BA.1.1 Variant of Concern (2022) (3)
- Protective efficacy of COVAXIN® against Delta and Omicron variants in hamster model (2022) (3)
- Bioinformatics characterization of envelope glycoprotein from Kyasanur Forest disease virus (2018) (3)
- Detection and isolation of SARS‐CoV‐2 Eta variant from the international travelers and local residents of India (2022) (3)
- Detection of the omicron variant in international travellers and their family contacts in India (2021) (3)
- Identification and phylogenetic analysis of herpes simplex virus-1 from clinical isolates in India (2019) (3)
- Reduced neutralizing antibody response in naïve Covishield vaccinees against Omicron emphasizes booster vaccination (2022) (3)
- Effectiveness of some Insecticides against Larval Population of Two Major Defoliators of Soybean (2018) (2)
- Replication of SARS-CoV-2 in cell lines used in public health surveillance programmes with special emphasis on biosafety (2022) (2)
- Genomic profile of SARS-CoV-2 Omicron variant and its correlation with disease severity in Rajasthan (2022) (2)
- Serosurvey of Malsoor virus among Rousettus leschenaulti bat & human population residing nearby Robber's cave, Mahabaleshwar, Maharashtra, India (2017) (2)
- Identification of Phasi Charoen-Like Phasivirus in Field Collected Aedes aegypti from Karnataka State, India. (2021) (2)
- Electron microscopy imaging of SARS-CoV-2 at different temperatures (2021) (2)
- Development of a Reverse Transcription Loop - Mediated Isothermal Amplification [RT-LAMP] as a early rapid detection assay for Crimean Congo Hemorrhagic Fever virus. (2022) (2)
- A case of breakthrough infection with SARS-CoV-2 Delta derivative and reinfection with Omicron variant in a fully vaccinated health care professional (2022) (2)
- Zika virus Pathogenesis in Infant Mice after Natural Transmission by the Bite of Infected Mosquitoes (2018) (2)
- Cases of SARS-CoV-2 reinfection with Omicron BA.2 post breakthrough infection with Delta and Kappa variants (2022) (2)
- Sequential determination of viral load, humoral responses and phylogenetic analysis in fatal and non-fatal cases of Crimean-Congo hemorrhagic fever patients from Gujarat, India, 2019 (2021) (2)
- Acute Encephalitis with Atypical Presentation of Rubella in Family Cluster, India (2018) (2)
- Clinico-epidemiological investigation on Varicella Zoster Virus indicates multiple clade circulation in Maharashtra state, India (2018) (2)
- Positivity of dengue and chikungunya among Crimean-Congo hemorrhagic fever-negative cases in India: 2013-2016. (2018) (2)
- Genetic Variation in Aedes Aegypti Mosquito Populations Along the West Cost of India and Their Susceptibility to Insecticides and Dengue Virus (2015) (2)
- Standardization & validation of Truenat™ point-of-care test for rapid diagnosis of Nipah (2021) (2)
- Comparison of SARS-CoV-2 VOC 202012/01 (UK variant) and D614G variant transmission by different routes in Syrian hamsters (2021) (2)
- Proactive preparedness for Cat Que virus: An Orthobunyavirus existing in India (2020) (2)
- A case report of the enterovirus-D68 associated severe acute respiratory illness in a pediatric case from India (2019) (2)
- Detection of Kyasanur forest disease in newer areas of Sindhudurg district of Maharashtra State (2018) (2)
- Experiences of Indian Council of Medical Research with tick-borne zoonotic infections: Kyasanur Forest disease & Crimean-Congo haemorrhagic fever in India with One Health focus (2021) (2)
- Point of Care Real Time PCR-based diagnostic for Kyasanur Forest Disease. (2021) (2)
- A case with SARS-CoV-2 reinfection from India (2021) (2)
- Isolation of SARS-CoV-2 B.1.1.28.2 (P2) variant and pathogenicity comparison with D614G variant in hamster model (2021) (2)
- Inactivation of SARS-CoV-2 by gamma irradiation (2021) (1)
- Omicron BA.2 lineage predominance in severe acute respiratory syndrome coronavirus 2 positive cases during the third wave in North India (2022) (1)
- Absence of Nipah virus antibodies in pigs in Mizoram State, North East India (2019) (1)
- Community transmission of SARS-CoV-2 with B.1.1.7 lineage in Mumbai, India (2021) (1)
- SARS-CoV-2 Kappa Variant Shows Pathogenicity in a Syrian Hamster Model. (2022) (1)
- Follow-up of Ebola Patient, 2014–2015 (2016) (1)
- Evaluation of immunogenicity post two doses of inactivated SARS-CoV-2 vaccine, Covaxin after six months (2022) (1)
- Identification of SARS-CoV-2 clusters from symptomatic cases in India (2020) (1)
- Delta variant SARS-CoV-2 infections in pediatric cases during the second wave in India (2021) (1)
- A case control investigation of COVID-19 associated mucormycosis in India (2022) (1)
- Development and Evaluation of Reverse Transcription Loop-Mediated Isothermal Amplification for Rapid and Real-Time Detection of Kyasanur Forest Disease Virus. (2021) (1)
- Waning natural and vaccine-induced immunity leading to reinfection with SARS-CoV-2 Omicron variant (2022) (1)
- Chemistry and Pharmacology of Bioactive Molecule -Coenzyme Q10: A Brief Note (2016) (1)
- Performance evaluation of Truenat™ Beta CoV & Truenat™ SARS-CoV-2 point-of-care assays for coronavirus disease 2019 (2021) (1)
- Authors’ response (2020) (1)
- Identification of Human Case of Avian Influenza A(H5N1) Infection, India (2022) (1)
- Understanding the dynamics of IgM & IgG antibodies in COVID-19-positive patients (2022) (1)
- Assessment of NS1 protein as an early diagnostic marker for Kyasanur forest disease virus. (2019) (1)
- Molecular epidemiology of a familial cluster of SARS-CoV-2 infection during lockdown period in Sant Kabir Nagar, Uttar Pradesh, India (2021) (1)
- Neutralization assays for SARS-CoV-2: Implications for assessment of protective efficacy of COVID-19 vaccines (2022) (1)
- Lack of evidence of viability and infectivity of SARS-CoV-2 in the fecal specimens of COVID-19 patients (2022) (1)
- Effectiveness of the ChAdOx1 nCoV-19 Coronavirus Vaccine (CovishieldTM) in Preventing SARS-CoV2 Infection, Chennai, Tamil Nadu, India, 2021 (2022) (1)
- Ultrastructure and Morphogenesis of Malsoor Virus: A Novel Phlebovirus Genetically Related to the Severe Fever with Thrombocytopenia Virus (2014) (1)
- Re-assessing the biosafety level requirement & defining surveillance need for Kyasanur forest disease virus: Changed paradigm (2021) (0)
- Pathogenicity of SARS-CoV-2 Omicron in Syrian hamsters and its neutralization with different Variants of Concern (2022) (0)
- Change of Editorship 2012 (2012) (0)
- Reviews of "SARS-CoV-2 variant B.1.617 is resistant to Bamlanivimab and evades antibodies induced by infection and vaccination" (2021) (0)
- P 2 variant with sera of natural SARS-CoV-2 infection and recipients of inactivated COVID-19 vaccine (2021) (0)
- Molecular Pathogenesis of Nipah Virus Infection (2021) (0)
- The species distribution of ticks & the prevalence of Kyasanur forest disease virus in questing nymphal ticks from Western Ghats of Kerala, South India (2021) (0)
- Running title: B.1.617.1 causes high pathogenicity in hamsters Summary: B.1.617.1 is the new SARS-CoV-2 lineage that emerged in India. Maximal body weight loss and higher viral load in hamsters infected with B.1.617.1. It caused pronounced lung lesions in hamsters (2021) (0)
- Lessons from the pandemic: Responding to emerging zoonotic viral diseases—a Keystone Symposia report (2022) (0)
- Corrigendum: Identification and characterization of novel mosquito-borne (Kammavanpettai virus) and tick-borne (Wad Medani) reoviruses isolated in India. (2019) (0)
- Authors' response. (2021) (0)
- Development of Nipah virus-specific IgM & IgG ELISA for screening human serum samples (2022) (0)
- Contents Vol. 55, 2012 (2012) (0)
- Editorial: Emerging SARS-CoV-2 variants: Genomic variations, transmission, pathogenesis, clinical impact and interventions (2023) (0)
- Phylogeography of Kyasanur Forest Disease virus in India (1957–2017) reveals evolution and spread in the Western Ghats region (2020) (0)
- Isolation and molecular characterization of coxsackievirus A6 and coxsackievirus A16 from a case of recurrent Hand, Foot and Mouth Disease in Mumbai, Maharashtra, India, 2018 (2020) (0)
- Clinical, immunological and genomic analysis of the post vaccinated SARS-CoV-2 infected cases with Delta derivatives from Maharashtra, India, 2021 (2022) (0)
- An imported case of fatal encephalitis associated with mpox virus infection, India, July 2022 (2023) (0)
- Molecular characterization & recombination analysis of complete enterovirus-88 isolated from acute flaccid paralysis cases in India (2023) (0)
- SARS-CoV-2 Delta and delta derivatives impact on neutralization of Covishield recipient sera (2022) (0)
- Title: Neutralization of Delta variant with sera of Covishield vaccinees and COVID-19 recovered vaccinated individuals Running title: Neutralization of Delta variant Authors: (2021) (0)
- Replication of SARS-CoV-2 in cell lines used in public health surveillance programmes with special emphasis on biosafety (2022) (0)
- Previous SARS-CoV-2 Infection Status Among the Current RT-PCR-Positive Individuals Affected During the Second Wave of COVID-19 Infections in Chennai, India (2022) (0)
- Needle‐free injection system delivery of ZyCoV‐D DNA vaccine demonstrated improved immunogenicity and protective efficacy in rhesus macaques against SARS‐CoV‐2 (2023) (0)
- Succession of insect pests of Soybean in Bundelkhand Region (2018) (0)
- Short communications The 2022 outbreak and the pathobiology of the coxsackie virus [hand foot and mouth disease] in India (2023) (0)
- Role of syrian hamsters and nonhuman primates in covid-19 research (2021) (0)
- Molecular characterization & recombination analysis of complete enterovirus-88 isolated from acute flaccid paralysis cases in India. (2023) (0)
- Low immune response after 1.5 years of primary SARS-CoV-2 infection and Covishield vaccination lead to SARS-CoV-2 reinfection (2022) (0)
- Protective efficacy of COVAXIN (cid:1) against Delta and Omicron variants in hamster model (2022) (0)
- Development and evaluation of indirect antibody ELISA assay for early diagnosis and surveillance of Crimean-Congo hemorrhagic fever infection in humans. (2022) (0)
- The Role of The Bhagwata Gita in A Woman's Life (2015) (0)
- Re-assessing the biosafety level requirement & defining surveillance need for Kyasanur forest disease virus: Changed paradigm (2021) (0)
- Possible Role of Accessory Proteins in the Viral Replication for the 20I/501Y.V1 (B.1.1.7) SARS CoV-2 Variant (2021) (0)
- Host immune responses in aged rhesus macaques against BBV152, an inactivated SARS-CoV-2 vaccine, and cross-neutralization with beta and delta variants (2023) (0)
- Comparison of neutralizing antibody response in first and second waves of SARS-CoV-2 pandemic in India (2021) (0)
- Molecular characterization of varicella zoster virus isolated from clinical samples in India (2021) (0)
- Growth Kinetics of Kyasanur Forest Disease Virus in Mammalian Cell Lines and Development of Plaque Reduction Neutralization Test. (2019) (0)
- Review 2: "SARS-CoV-2 variant B.1.617 is resistant to Bamlanivimab and evades antibodies induced by infection and vaccination" (2021) (0)
- Neutralization assays for SARS-CoV-2: Implications for assessment of protective efficacy of COVID-19 vaccines (2022) (0)
- Possible role of accessory proteins in the viral replication for the 20I/501Y.V1 (B.1.1.7) SARS-CoV-2 variant (2021) (0)
- Serosurvey for Nipah virus in bat population of southern part of India (2022) (0)
- Authors’ response (2015) (0)
- A case of human buffalopox in Malappuram, India: The role of mpox surveillance in 2022 (2023) (0)
- BIOINFORMATICS AND ADME DATABASES ARE USED IN CAAD (2021) (0)
- Molecular study of Cryptosporidium spp., from rat and mice (2018) (0)
- SARS-CoV-2 Delta derivatives impact on neutralization of Covishield recipient sera (2021) (0)
- Reduced severity of SARS-CoV-2 infection by Kappa variant of interest (B.1.617.1) in a healthcare worker post-vaccination from Gujarat, India (2022) (0)
- Molecular characterization of varicella zoster virus isolated from clinical samples in India. (2022) (0)
- Mapping the epitope in Epstein Barr Virus nuclear antigen-1 that elicits cross-reactivity with dsDNA (101.43) (2011) (0)
- Certification & validation of biosafety level-2 & biosafety level-3 laboratories in Indian settings & common issues (2017) (0)
- Feeding Value of Ensiled Sugar Beet Pulp in Cattle (2020) (0)
- First case of Zika virus infection during an outbreak of chikungunya in a rural region of Maharashtra state, India. (2022) (0)
- Staphylococcal scalded skin syndrome (SSSS): An Overview (2016) (0)
- Persistence of infectious monkey pox virus on the surfaces of isolation ward in a hospital setting, India (2023) (0)
- Detection of Crimean-Congo hemorrhagic fever and theileriosis in livestock, Madhya Pradesh, Central India (2020) (0)
- Prevalence and spatial distribution of Ixodid tick populations in the forest fringes of Western Ghats reported with human cases of Kyasanur forest disease and monkey deaths in South India (2018) (0)
- Characterization and sequence analysis of fibroblast growth factor 2 gene in buffalo (Bubalus bubalis) (2013) (0)
- Isolation and characterization of SARS-CoV-2 VOC, 20H/501Y.V2, from UAE travelers (2021) (0)
- FINAL PUBLISHED Ms (2014) (0)
- Crimean-Congo Hemorrhagic Fever: Current Scenario in India (2013) (0)
- Nairobi Sheep Disease Virus (2016) (0)
- Antibody responses to Sputnik Vaccination in naïve and COVID 19-recovered vaccine recipients, India (2022) (0)
This paper list is powered by the following services:
Other Resources About Pragya D. Yadav
What Schools Are Affiliated With Pragya D. Yadav?
Pragya D. Yadav is affiliated with the following schools: